Lawrence B. Cohen’s Quince Therapeutics QNCX Stock Holding History

Lawrence B. Cohen’s Portfolio QNCX Stock Details QNCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-56	Closed	-$12.5K	–	46
2023 Q3	$12.5K	Hold	56	–	–	0.01%	60
2023 Q2	$16.7K	Hold	56	–	–	0.01%	65
2023 Q1	$17.4K	Hold	56	–	–	0.01%	61
2022 Q4	$7.09K	Hold	56	–	–	﹤0.01%	93
2022 Q3	$15K	Hold	56	–	–	0.01%	64
2022 Q2	$25K	Hold	56	–	–	0.02%	62
2022 Q1	$69K	Hold	56	–	–	0.04%	62
2021 Q4	$140K	Hold	56	–	–	0.05%	97
2021 Q3	$1.02M	Buy	56 +11	+24%	+$175K	0.54%	48
2021 Q2	$477K	Hold	45	–	–	0.24%	56
2021 Q1	$324K	Hold	45	–	–	0.18%	64
2020 Q4	$250K	Hold	45	–	–	0.14%	68
2020 Q3	$450K	Hold	45	–	–	0.27%	58
2020 Q2	$417K	Hold	45	–	–	0.28%	55
2020 Q1	$410K	Buy	+45	New	+$444K	0.32%	55

Other funds holding QNCX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Lawrence B. Cohen's QNCX Position: Q4 2023 in Review

Lawrence B. Cohen sold out of Quince Therapeutics (QNCX) in Q4 2023, closing a stake of 56 shares — an estimated $12.5K sold.

Lawrence B. Cohen first reported a position in QNCX in Q1 2020 and held it in 15 quarters. The position peaked at $1.02M in Q3 2021. 42 funds tracked by Wall St. Rank hold QNCX as of Q4 2023.

Lawrence B. Cohen reported no remaining Quince Therapeutics position as of Q4 2023 after selling out during the quarter.
Lawrence B. Cohen sold 56 Quince Therapeutics shares in Q4 2023, an estimated $12.5K.
Lawrence B. Cohen first reported a position in Quince Therapeutics in Q1 2020 and held it in 15 quarters.
Lawrence B. Cohen's Quince Therapeutics position peaked at $1.02M in Q3 2021.
42 funds tracked by Wall St. Rank held Quince Therapeutics as of Q4 2023.

Based on Lawrence B. Cohen's 13F filing for Q4 2023, filed 9 Feb 2024.